Published on 15 Mar 2024 on GuruFocus.com via Yahoo Finance
Insider Sell: CFO Michael Maclean Sells 40,000 Shares of Avidity Biosciences Inc (RNA)
Michael Maclean, Chief Financial Officer of Avidity Biosciences Inc (NASDAQ:RNA), sold 40,000 shares of the company on March 13, 2024, according to a recent SEC filing. The transaction was executed at an average price of $24.52 per share, resulting in a total value of $980,800.
Avidity Biosciences Inc is a biotechnology company focused on the discovery and development of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs). The company aims to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target genetic drivers of disease.